UBE2Z expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.922200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.573200E-01
Normal-vs-Stage2
7.409800E-01
Normal-vs-Stage3
1.279790E-01
Normal-vs-Stage4
9.947200E-01
Stage1-vs-Stage2
3.133600E-01
Stage1-vs-Stage3
1.157640E-01
Stage1-vs-Stage4
2.601800E-01
Stage2-vs-Stage3
6.250300E-02
Stage2-vs-Stage4
6.985800E-01
Stage3-vs-Stage4
9.369600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.984200E-01
Normal-vs-AfricanAmerican
4.591400E-01
Normal-vs-Asian
3.585800E-01
Caucasian-vs-AfricanAmerican
6.233400E-01
Caucasian-vs-Asian
4.096800E-01
AfricanAmerican-vs-Asian
9.034600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.758600E-01
Normal-vs-Female
7.087000E-01
Male-vs-Female
8.182600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.277200E-01
Normal-vs-Age(41-60Yrs)
7.617400E-01
Normal-vs-Age(61-80Yrs)
4.591800E-01
Normal-vs-Age(81-100Yrs)
5.462800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.446000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.023000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.908400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.954000E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.736300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.969400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.179400E-01
Normal-vs-Daily Drinker
3.453800E-01
Normal-vs-Weekly Drinker
6.440800E-01
Normal-vs-Occasional Drinker
5.519000E-01
Normal-vs-Social Drinker
9.075600E-01
Non Drinker-vs-Daily Drinker
4.936800E-01
Non Drinker-vs-Weekly Drinker
1.911990E-01
Non Drinker-vs-Occasional Drinker
7.355600E-04
Non Drinker-vs-Social Drinker
1.470150E-02
Daily Drinker-vs-Weekly Drinker
4.710000E-01
Daily Drinker-vs-Occasional Drinker
6.538500E-03
Daily Drinker-vs-Social Drinker
6.725600E-02
Weekly Drinker-vs-Occasional Drinker
8.022000E-02
Weekly Drinker-vs-Social Drinker
3.413600E-01
Occasional Drinker-vs-Social Drinker
3.558200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.528200E-02
Normal-vs-Grade 2
1.705630E-02
Normal-vs-Grade 3
5.482900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.956800E-01
Grade 1-vs-Grade 3
2.251700E-02
Grade 1-vs-Grade 4
6.528200E-02
Grade 2-vs-Grade 3
1.535810E-01
Grade 2-vs-Grade 4
1.705630E-02
Grade 3-vs-Grade 4
5.482900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.117800E-01
Normal-vs-NonDiabetic
7.478000E-01
Diabetic-vs-NonDiabetic
9.836000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.958400E-01
Normal-vs-NoPancreatitis
5.872400E-01
Pancreatitis-vs-NoPancreatitis
4.139200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.505000E-01
Normal-vs-N1
7.486400E-01
N0-vs-N1
5.682600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.184800E-01
Normal-vs-TP53-NonMutant
4.670400E-01
TP53-Mutant-vs-TP53-NonMutant
3.441000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
